AgeX Therapeutics (SER) P/E (2018 - 2026)
AgeX Therapeutics (SER) P/E from Nov 29, 2018 to Jul 20, 2026. The TTM AgeX Therapeutics (SER) P/E is -1.18. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of AgeX Therapeutics (SER)
| Year | P/E | Change |
|---|---|---|
| 2026 | -1.18 | +15.27% |
| 2025 | -1.03 | -72.87% |
| 2024 | -3.78 | -139.34% |
| 2023 | 9.61 | -555.39% |
| 2022 | -2.11 | -55.74% |
| 2021 | -4.77 | -7.27% |
| 2020 | -5.14 | -8.77% |
| 2019 | -5.64 | -59.13% |
| 2018 | -13.80 | N/A |
Comparison AgeX Therapeutics (SER) P/E with competitors
AgeX Therapeutics (SER) P/E is -1.18.